Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

X4 Pharmaceuticals, Inc Director's Dealing 2021

Oct 18, 2021

34355_dirs_2021-10-18_23733a77-0a4f-447e-b424-2fad2a8c0bf6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2021-10-14

Reporting Person: de Craecker Francoise (Director)

More from X4 Pharmaceuticals, Inc

Regulatory Filings 2026
May 12
Regulatory Filings 2026
May 6
Interim / Quarterly Report 2026
May 6
Annual Report 2026
Mar 20
Regulatory Filings 2026
Mar 20
Proxy Solicitation & Information Statement 2026
Mar 20
Annual Report 2026
Mar 17
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 17
View all filings →